Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT04516109

Modifications of Devices for Hip Arthroscopy

This is protocol is intended to demonstrate the principal investigator's improvements and modifications of a hip capsule side fixed slotted cannula for continued access to the hip joint and a bone graft delivery tool set for grafting subchrondral cysts during hip arthroscopy procedure.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Colorado, Hip Preservation Center, Orthopedic Department, Boulder, Colorado, United States

Loading trial locations.

About this study

Femoroacetabular impingement (FAI) and acetabular dysplasia represent the two most common causes of secondary osteoarthritis of the hip1-3 and the two main indications for Hip Preservation procedures. Most patients with these pathologies will undergo Hip Arthroscopy, either alone, or combined with bony realignment procedures. Hip arthroscopy has grown exponentially over the past 15 years and is currently being leveraged in the diagnosis and treatment of a wide range of hip joint problems.

In an effort to improve surgical techniques, make surgeries faster and reproducible, mitigate complications and increase patient safety, surgeons modify and improve commercially available and commonly used non-significant risk devices with the above goals in mind.

For these reasons, the Principal Investigator (PI) modified and improved two devices for hip arthroscopy. These include the modified (1) hip capsule side fixed slotted cannula for continued access to the hip joint and (2) bone graft delivery tool set for grafting subchrondral cysts arthroscopically during hip arthroscopy procedure. After utilizing these modified devices clinically, the PI has been impressed with their impact and thus aims to demonstrate that the modifications provide significant improvements in surgical flow and technique, minimize surgical time (per technical phase), minimize surgical costs, result in an absolute low incidence of surgical complications, and ultimately improve patient outcomes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Males or females between the ages of 18 and 60 years diagnosed with FAI, Hip Dysplasia or the combination of the two.
  • Persistent hip pain accompanied by mechanical symptoms refractory to nonoperative management lasting at least 3 months.
  • Reproducible clinical examination findings suggestive of impingement and/or decreased range of motion, and positive radiographic findings on radiography, computed tomography with 3-dimensional reconstruction, and magnetic resonance imaging.
  • Joint-space width > 3 mm on all views of plain radiography and 3-dimensional computed tomography.
  • Patients undergoing hip arthroscopy for the treatment of FAI, Hip Dysplasia, or the combination of the two by the Principal Invesitgator.

Exclusion criteria

  • Age <18 years.
  • Prisoners.
  • Pregnant women.
  • Decisionally challenged.
  • Does not speak or understand English.

Treatment and study plan

Modified hip capsule side fixed slotted cannula

Device

Modified hip capsule side fixed slotted cannula used during surgery to allow for continued access to the hip joint.

Modified bone graft delivery tool set

Device

Modified bone graft delivery tool set for grafting subchrondral cysts arthroscopically during hip arthroscopy procedure.

Primary outcomes

  1. Surgical time per technical phase measured in minutes

    Time frame: 1 Day

    • We aim to demonstrate that the use of the modified device for hip arthroscopy is fast and efficient as measured by surgical time per technical phase (i.e. arthroscopic labral repair phase and arthroscopic bone grafting phase).
    • Arthroscopic Labral Repair Phase: During hip arthoscopy, the surgical time of the arthroscopic labral repair phase will be collected.
    • Arthroscopic Bone Grafting Phase: During hip arthoscopy, the surgical time of the bone grafting of the hip joint phase will be collected.
    • In this design, the technical phase recorded will either be: 1) duration of arthroscopic labral repair phase (in patients only undergoing arthroscopic labral repair) or 2) duration of arthroscopic bone grafting phase (in patients undergoing arthroscopic bone grafting).

Secondary outcomes

  1. Rate of Surgical Complications

    Time frame: Up to 24 months

    Total number of complications determined to be related to the hip arthroscopy procedure.

  2. Surgical costs per device used

    Time frame: 1 Day

    Cost to use each device in surgery, measured in US dollars.

  3. Patient Outcomes: Post-operative Pain

    Time frame: Post operative up to Day 9

    Pain, as assessed via a visual analog scale. Possible scores range from 0-100, with 0 indicating no pain and 100 indicating the most severe pain and a worse outcome.

  4. Patient Outcomes: Change in Pain

    Time frame: Pre-treatment, Week 6, Month 3, Month 6, Month 12, Month 24

    Pain, as assessed via a visual analog scale. Possible scores range from 0-100, with 0 indicating no pain and 100 indicating the most severe pain and a worse outcome.

  5. Patient Outcomes: Change in International Hip Outcome Tool (IHOT-12) Scores

    Time frame: Pre-treatment, Week 6, Month 3, Month 6, Month 12, Month 24

    The International Hip Outcome Tool (IHOT-12) measures both health-related quality of life and changes after treatment in young, active patients with hip disorders. Patients indicate their responses to the various questions by marking a 100 mm visual analog scale. The total score is calculated by calculating the mean of the participant's responses. Possible scores range from 0-100 with 0 indicating the worst and 100 indicating the best possible quality of life.

  6. Patient Outcomes: Change in Non-Arthritic Hip Scores

    Time frame: Pre-treatment, Week 6, Month 3, Month 6, Month 12, Month 24

    The Non-Arthritic Hip score is a self-administered hip score measuring function and quality of life designed for use in younger patients with higher activity demands and treatment expectations than older patients with degenerative joint disease. Possible scores range from 0-4, with 0 indicating the worst and 4 indicating the best level of function and outcome for the patient.

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Registry information

Important dates

Study start
2020
Primary completion
2024
Study completion
2026
First posted
Aug 18, 2020
Registry last updated
Feb 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.